How does enteric coating change aspirin’s onset?
Enteric coating delays aspirin’s absorption by preventing the tablet from dissolving in the stomach. Because the coating is designed to resist the stomach’s acidic environment and dissolve later (typically in the small intestine), the drug reaches the absorption site later than it would with a non–enteric-coated tablet. That delay generally shifts aspirin’s onset of action later in time.
What happens if aspirin dissolves in the stomach instead?
Non–enteric-coated aspirin dissolves in the stomach much sooner, so its active absorption begins earlier. With earlier absorption, you generally see an earlier onset of action compared with enteric-coated aspirin.
Why does the site of absorption matter for onset timing?
Onset reflects when enough aspirin (or its active form) reaches the bloodstream to produce a clinical effect. Enteric coating pushes the location and timing of dissolution/absorption away from the stomach and toward the intestine, so there is a lag before therapeutic blood levels are reached.
Does enteric coating affect the strength of aspirin’s effect?
Enteric coating primarily changes timing, not the inherent analgesic or antiplatelet potency of aspirin. The main difference is that the effect starts later because the medication arrives later to where it can be absorbed.
What patients notice in practice?
People using enteric-coated aspirin may experience slower symptom relief (for pain/fever) than with non–enteric-coated formulations, since the onset is delayed by delayed dissolution and absorption. The delay can matter most when rapid onset is the goal.
Trade-off: delayed onset versus stomach irritation
A key reason for enteric coating is to reduce direct contact of aspirin with the stomach lining, which can lower gastric irritation risk. That comes at the cost of slower onset.
How much delay should someone expect?
The exact time shift depends on factors like formulation, gastric emptying time, and intestinal conditions, so the delay can vary across individuals and circumstances. Enteric coating is consistently associated with a later onset than immediate-release (non–enteric-coated) aspirin, but the magnitude of the delay is formulation- and person-dependent.